The PI3K pathway is commonly deregulated in cancer, with the most common events being mutation or increased gene copy numbers of PIK3CA or other PI3K isoforms, loss of expression of the pathway suppressors (for example, PTEN), or hyperactivation of RTKs through receptor overexpression or activating mutations (Table 1). Here, PTEN is linked to cancer.